It appears as though hardcore “Red States” are starting to see the benefits of legalizing medical marijuana. At a time when other states are considering similar strategies as Colorado, Washington and New Mexico, the outlook for federal legalization of marijuana is starting to become more of a possibility.
It has been reported that Louisiana Governor Bobby Jindal will sign a set of bills for marijuana reform. This is possibly the strongest example to date that cultural norms are changing in the state and in surrounding, conservative, regions. State representative Austin Badon has been a strong voice for marijuana reform in Louisiana over the last several years. He’s seen a great shift in political interest since the moment he first lobbied for marijuana reform. “Over the last few years, legislators, they didn’t even want to talk about marijuana reform. They would not even give the bill a fair hearing in committee or even schedule it for a committee,” he explained. Badon has long advocated that legalization of marijuana could provide the state with increased tax revenues, reduce prison expenses, and provide much needed treatment for people suffering from debilitating conditions.
One of the bills that Governor Jindal is expected to sign looks to reduce jail time and fines for people who were previously arrested for marijuana possession. The measure looks to significantly reduce jail costs, saving the state about $17 million annually. In the past, Jindal has emphasized the need for sentencing reform, citing over crowded prison systems and high costs for holding prisoners who aren’t felons.
The second bill permits pharmacies to dispense medical marijuana to patients who are registered with the state. This would create a system in which physicians diagnose treatment of conditions such as epilepsy, Crohn’s disease or pain for cancer patients undergoing chemotherapy, providing them with prescriptions for marijuana. Medical marijuana has actually been legal in Louisiana since 1971, but there were never rules to regulate its cultivation and sales. But now, with companies such as BioTrackTHC™ providing POS and Inventory Management Solutions for growers and vendors, regulatory agencies have a platform to view all plant info from seed to sale.
Passing such bills was once an unthinkable act. But as other states are finding measures to regulate the growth and sales of marijuana and provide audit reports to regulatory agencies, those who were once strongly opposed are seeing the benefits. By initially legalizing medical marijuana, the state sets a time pattern that may one day lead to full legalization of recreational marijuana as well. Political analyst Mike Sherman doesn’t think citizens shouldn’t expect the legalization of recreational marijuana any time soon, but he is optimistic that it will happen one day. He thinks the new measures are a gradual push towards full legalization of marijuana in the not too distant future. “It’s a small step towards decriminalization, not yet legalization, but that’s the direction the legislature is heading in, keeping our prisons from becoming full of low level drug offenders.”
Since 2010, BioTrack has provided the legal cannabis operators with the industries’ leading seed to sale tracking and dispensary point of sale software. Whether you operate a cultivation site, manufacturing and processing facility, medical or recreational dispensary or a business that covers the full vertical, we’ve got you covered when it comes to compliance.
Our extensive seed-to-sale software allows licensed operators to remain compliant while helping to identify key data points to streamline and optimize inventory management at each phase of the operation; cultivation, processing, destruction and waste, transportation, lab testing and dispensing.
Along with BioTrack’s best-in-class commercial software, we also provide government track and trace solutions and currently hold government contracts in nine states. This allows lawmakers and regulatory agencies to ensure a transparent and compliant program from top to bottom.
In 2021 BioTrack became a part of Forian, Inc. Forian is a Delaware corporation created by the combination of Helix Technologies, Inc. (“Helix”) and Medical Outcomes Research Analytics, LLC (“MOR”). As of March 2, 2021, each of Helix and MOR are wholly owned subsidiaries of Forian. Forian represents the unique intersection of a leading cannabis technology platform with intelligent data science yielding the combined power to drive innovation and transparency across the healthcare and cannabis industries. For more information, see our website, which remains in process.
Are you interested in learning more about BioTrack or the cannabis industry in general? Check out our careers page to learn more about what it takes to join our winning team or take a look at our industry-leading blog for great news and information about the cannabis industry.